Karben, Germany

Heike Stump

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heike Stump. Retrieved from https://idiyas.com/inventor/heike-stump-hkfg1av6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heike Stump - Innovator in Antifungal Research

Introduction

Heike Stump, an innovative inventor based in Karben, Germany, is recognized for her contributions to the field of microbiology, particularly in antifungal research. With a focus on developing peptides from the scleroderma texense, her work has opened new avenues for potential treatments against fungal infections.

Latest Patents

Stump holds a patent for "Antifungal peptides from scleroderma texense," showcasing her pioneering efforts in the pharmaceutical industry. This invention highlights the importance of natural compounds in combating resistant fungal strains, thus enhancing therapeutic options available for patients.

Career Highlights

Heike Stump is employed at Aventis Pharma Deutschland GmbH, where she applies her expertise in drug development and research. Her dedication to advancing pharmaceutical solutions has significantly impacted the company's initiatives in creating effective antifungal treatments.

Collaborations

Throughout her career, Stump has collaborated with notable colleagues such as Wilhelm Stahl and Joachim Wink. Working alongside these esteemed professionals has fostered an environment of innovation and shared expertise, further enriching her research endeavors.

Conclusion

Heike Stump stands out as a distinguished inventor in the field of antifungal research. Her patent and collaborations demonstrate her commitment to enhancing public health through innovative solutions in pharmaceuticals. Her ongoing contributions are likely to influence the future of antifungal therapies and inspire the next generation of researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…